Neuroprotection & Drug Delivery
Neuroprotektion & Wirkstoff-Applikation
Home » Labs » Clinical Research Labs » Schnichels Lab
Schnichels Lab
Our group is focusing on four main aspects:
- In applying DNA-nanotechnology we have developed a drug delivery platform that can be combined with different kinds of drugs to improve their ocular uptake.
- By developing new organ culture models, we are actively contributing to the goal of reducing animal experiments by using alternative models to investigate disease mechanisms and to test novel therapeutic approaches.
- We are mainly focusing on improving the treatment of retinal ganglion cell (RGC) diseases by investigating underlying pathomechanisms of RGC death and testing different therapy options.
- In numerous collaborations with pharma, bio- and medtech companies we also perform biocompatibility and efficacy tests for new drugs or medical devices.
As a clinical research group we are also closely collaborating with the physicians working at the eye hospital to transfer research from bench to bedside.
The Leaflet
Download the leaflet of the Schnichels Lab [PDF, 1.0 MByte]